Quick Answer
Skye Bioscience, Inc. reported Cash And Cash Equivalents At Carrying Value of $5.88 million for the year ending 2025.
- Skye Bioscience, Inc. showed a decrease of -91.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Skye Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2011 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $12.4 thousand | Q3 2012: $13.1 thousand | Q4 2012: $26.4 thousand | Q1 2013: $23.3 thousand | Q2 2013: $29.7 thousand | Q3 2013: $37.2 thousand | Q4 2013: $52.2 thousand | Q1 2014: $46.5 thousand | Q2 2014: $50.0 thousand | Q2 2014: $528.5 thousand | Q3 2014: $39.2 thousand | Q1 2015: $176.7 thousand | Q2 2015: $601.3 thousand | Q3 2015: $4.34 million | Q1 2016: $2.06 million | Q2 2016: $831.7 thousand | Q3 2016: $319.9 thousand | Q1 2017: $380.3 thousand | Q2 2017: $108.9 thousand | Q3 2017: $42.0 thousand | Q1 2018: $2.95 million | Q2 2018: $1.87 million | Q3 2018: $1.06 million | Q4 2018: $1.85 million | Q1 2019: $4.41 million | Q2 2019: $2.81 million | Q3 2019: $1.32 million | Q4 2019: $1.83 million | Q1 2020: $563.9 thousand | Q2 2020: $102.5 thousand | Q3 2020: $4.22 million | Q4 2020: $2.47 million | Q1 2021: $5.15 million | Q2 2021: $5.19 million | Q3 2021: $11.09 million | Q4 2021: $8.98 million | Q1 2022: $6.01 million | Q2 2022: $2.93 million | Q3 2022: $415.4 thousand | Q4 2022: $1.24 million | Q1 2023: $2.67 million | Q2 2023: $553.4 thousand | Q3 2023: $5.13 million | Q1 2024: $83.34 million | Q2 2024: $74.12 million | Q3 2024: $67.41 million | Q1 2025: $46.42 million | Q2 2025: $23.84 million | Q3 2025: $18.44 million.
- Over the full 12 years of available data (2011 to 2025), Skye Bioscience, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 42,177.5%.
- Historical annual values: Fiscal year 2025: $5.88 million | Fiscal year 2024: $68.42 million | Fiscal year 2023: $1.26 million | Fiscal year 2018: $1.85 million | Fiscal year 2017: $260.0 thousand | Fiscal year 2016: $64.8 thousand | Fiscal year 2015: $3.22 million | Fiscal year 2014: $207.3 thousand | Fiscal year 2014: $1.03 million | Fiscal year 2013: $52.2 thousand | Fiscal year 2012: $26.4 thousand | Fiscal year 2011: $13.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: